Associations Among Lactation, Maternal Carbohydrate Metabolism, and Cardiovascular Health by Stuebe, Alison
Associations between lactation, maternal carbohydrate 
metabolism, and cardiovascular health
Alison Stuebe, MD, MSc [Associate Professor]
Maternal-Fetal Medicine, University of North Carolina School of Medicine, Chapel Hill, NC and 
Maternal and Child Health, Carolina Global Breastfeeding Institute, Gillings School of Global 
Public Health
Introduction
In mammalian reproductive physiology, lactation follows pregnancy. Meeting the nutritional 
needs of the infant imposes a substantial burden on maternal physiology, requiring about 500 
calories per day. Growing evidence suggests that premature weaning disrupts this 
physiology and impacts long-term maternal health. In the postpartum period, mothers who 
are not breastfeeding have higher glucose and insulin levels, and lower disposition index, 
compared with lactating mothers. Long term, never or curtailed breastfeeding is associated 
with maternal health risks, including higher rates of hypertension, diabetes, and myocardial 
infarction. These data suggest that maternal lactation may be a modifiable risk factor for 
long-term maternal health. This manuscript reviews the physiology of lactation, discusses 
short-term associations between current lactation and cardiometabolic risk markers, and 
reviews observational data linking lactation with maternal health outcomes. Hypothesized 
mechanisms are also discussed, including the potential for confounding by maternal health 
behaviors and preexisting metabolic disease. Finally, evidence-based clinical 
recommendations are reviewed that optimize a woman's chances of achieving her 
breastfeeding goals.
Physiology of lactation
Lactation is a two-person organ system, depending on the integrated neurobehavioral 
dynamics of mother and infant. These dynamics begin during the mother's adolescence, 
when cyclic stimulation by estrogen and progesterone facilitates development of the breast 
ducts. During pregnancy, estrogen, progesterone, insulin, cortisol and thyroid hormone all 
contribute to the elaboration of glandular tissue. By 20 weeks' gestation, the maternal breast 
is capable of milk synthesis, as indexed by the presence of lactose in maternal urine1. After 
delivery of the placenta, falling progesterone levels are thought to trigger onset of secretory 
activation, marked clinically by milk "coming in" as gap junctions between lactocytes close, 
trapping lactose and water in the alveolar lumen. The hormone prolactin stimulates milk 
synthesis, while oxytocin from the posterior pituitary triggers milk secretion. Oxytocin 
causes contraction of myoepithelial cells surrounding alveoli in the breast, allowing transfer 
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of the milk through the ducts to the areola. At the breast, the infant's oromotor organization 
determines whether milk is successfully transferred. Latch and milk transfer require mature 
infant suck-swallow-breath function. In addition, to establish and sustain lactation, mothers 
must learn to identify and respond to infant feeding cues.
The synthesis of milk depends on availability of substrate and on both endocrine and 
autocrine regulation. In early lactation, endocrine factors appear to predominate; prolactin 
levels are highest in the early weeks of breastfeeding. Thyroxin, growth hormone, cortisol 
and insulin also contribute to normal milk synthesis. Recent evidence from the milk 
transcriptome suggests that insulin signaling plays a key role in milk synthesis. Among 
women with insulin resistance (indexed by HOMA) and low milk supply, Lemay et al found 
increased expression of PTPRF, which interferes with insulin-receptor B signaling and 
thereby may inhibit milk synthesis2. Milk synthesis mobilizes maternal energy stores: 
lactating women require about 500 kcal per day to produce milk to meet the needs of an 
exclusively breastfed infant3. Evidence suggests that in well-nourished women, the majority 
of energy from milk production is derived from dietary intake; however, modest calorie 
restriction does not adversely affect milk supply. In a clinical trial of weight loss during 
lactation among overweight women, dietary restriction of about 500 kcal a day did not 
adverse affect infant growth4.
Lactation and short-term markers of metabolic health
Conventional wisdom holds that breastfeeding helps women to lose weight. Lactation 
mobilizes about 500 kcal per day, roughly equivalent to 45 minutes of running at a 6 mile-
per-hour pace. Evidence from observational studies suggests that longer, more intensive 
breastfeeding is associated with greater weight loss after pregnancy. Dewey et al 
prospectively followed 46 breastfeeding women and 39 women who weaned by 3 months; 
they found that breastfeeding women had 2 kg more weight loss in the first year than the 
non-breastfeeding women5. In the Danish National Birth Cohort, greater breastfeeding 
duration and intensity were associated with reduced retained gestational weight gain: 
Women who gained 12 kg during pregnancy and fully breastfed for 6 months were below 
their pregravid weight by 6 months postpartum, whereas women who breastfed less than 1 
week were nearly 2 kg over their pregravid weight6. Other studies have not found long-term 
differences in retained weight: Ohlin and Rossner found that overall weight loss from 2.5 to 
12 months was similar, regardless of breastfeeding status. In a subsequent analysis7, the 
authors found that women who snacked 3 or more times a day did not lose weight with 
lactation, suggesting that relatively small differences in dietary habits can counteract effects 
of lactation on maternal weight.
Only one randomized controlled trial has quantified the effect of lactation intensity on 
maternal weight. Dewey et al randomized 141 exclusively breastfeeding mother-infant dyads 
in Honduras to continued exclusive breastfeeding from 4 to 6 months vs. introduction of 
complementary foods8. Women who continued to exclusively breastfeed lost 600 g more 
during the two-month period than women whose infants received complementary foods. 
Interestingly, the authors estimated that the exclusively breastfeeding mothers expended an 
additional 5520 kcal during this two-month period; 600g of fat, at 9 kcal/g, would provide 
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5400 kcal, meeting almost all of this excess energy need. While these results provide 
randomized control trial evidence that greater lactation intensity increases weight loss, the 
generalizability of these data is unclear in high-income countries where nutrient-dense food 
is abundant.
Several authors have found that lactation is associated with differences in glucose and 
insulin homeostasis among women with recent gestational diabetes. Kjos et al measured 
glucose and insulin levels among 809 primarily Latina women with recent gestational 
diabetes. At 4 to 12 weeks postpartum, non-lactating women had higher fasting and 2-hour 
post-load glucose values9. More recently, Gunderson et al measured glucose tolerance as a 
function of breastfeeding intensity at 6–9 weeks postpartum and found that exclusively or 
mostly formula-feeding mothers more likely to have impaired glucose tolerance than 
exclusively breastfeeding mothers (41.5 vs 24.6%, p=0.02). This association was also 
present in an analysis restricted to obese women (53.1 vs. 26.2%, p=0.03). Authors reported 
similar findings in the Atlantic Diabetes in Pregnancy cohort: compared with formula 
feeding women, women with recent gestational dysglycemia who were currently 
breastfeeding had an MV-adjusted 0.42 (0.20–0.89) odds of dysglycemia at 12 weeks 
postpartum10. Gunderson further quantified the acute effect of breastfeeding on glucose and 
insulin metabolism by comparing fasting and 2-hour post-load glucose values among 
lactating women who did or did not breastfeed during the oral glucose tolerance test. Fasting 
glucose and insulin values were similar in the two groups, but post-load levels were lower 
among women who breastfed during the test (MV-adjusted predicted values for glucose 
108.8 vs 115.0 mg/dL) suggesting an acute effect of breastfeeding on maternal insulin and 
glucose homeostasis11.
Lactation is also associated with differences in lipid homeostasis. Darmady and Postle12 
followed 34 women from prior to conception through pregnancy and the postpartum period 
and found that triglyceride levels retuned to baseline 13 weeks earlier in lactating than in 
non-lactating women (p < 0.001). Other authors have identified a protective association 
between lactation and HDL metabolism at six weeks9,13#565 and 3 months14 postpartum. In 
women who continue breastfeeding for 1 year, higher levels of HDL appear to persist until 
weaning15. In the Kaiser SWIFT cohort, greater breastfeeding intensity was associated with 
higher HDL and lower LDL16 at 6 to 9 weeks postpartum.
Finally, lactation is associated with lower blood pressure in the postpartum period. The 
hormone oxytocin plays a central role in milk ejection via its effects on myoepithelial cells, 
and oxytocin modulates in vascular endothelial function17. In animal studies, Petersson et 
al.18,19 found that oxytocin administration decreased blood pressure in rats, with effects that 
persisted for 10 to 21 days after drug administration was discontinued. Observational studies 
suggest that nursing mothers have diminished autonomic responses to stressors. Mezzacappa 
et al20 found evidence that exclusive breastfeeding was associated with lower heart rates, 
increased vagal tone, and decreased sympathetic response to laboratory stress, compared 
with values in non-exclusive breast feeders and non-postpartum controls.
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Lactation and long-term maternal cardiometabolic health
In observational studies, authors have reported lasting associations between lactation 
duration and maternal health outcome. Longer lifetime breastfeeding duration is associated 
with reduced maternal obesity. In a longitudinal cohort in La Crosse, Wisconsin, Rooney 
and Schauberger21 found long-term differences in adiposity by breastfeeding history. A 
decade after the index pregnancy, they reported that women who breastfed for more than 12 
weeks weighed 3.7 kg less than women who had never breastfed, adjusting for gestational 
weight gain, weight loss by 6 months postpartum, and aerobic exercise. In the UK Million 
Women's Study, Bobrow et al measured associations between breastfeeding duration per 
child and body mass index at a mean age of 57 years22. Each 6-months of breastfeeding was 
associated with a 0.22 kg/m2 decrease in body mass index.
Longer lifetime lactation is also associated with lower risk of Type 2 Diabetes. In the Nurses' 
Health Studies, each year of lifetime lactation was associated with a 15% reduction in 
incident Type 2 Diabetes during the 15 years following a women's last birth23. Lifetime 
lactation was similarly associated with lower prevalent diabetes in the Women's Health 
Initiative24. In a longitudinal cohort study among Kaiser patients, never breastfeeding was 
associated with a 1.4-fold risk of Type 2 diabetes, compared with breastfeeding for at least 6 
months per child25. Authors have reported similar associations between lifetime lactation 
and Type 2 Diabetes in cohorts in China26, Australia27, Norway28, and Europe29. A recent 
meta-analysis found a non-linear association between lifetime lactation duration and 
incident type 2 diabetes risk30.
The inverse association between lactation and incident type 2 diabetes has been found in 
some cohorts of women with Gestational Diabetes. In the Nurses' Health Study II, lactation 
duration was marginally associated with reduced incident Type 2 Diabetes in unadjusted 
models (HR per year 0.90, 95% CI 0.81–1.01, p for trend = 0.05), but not in adjusted 
models23. However, in German prospective cohort study of women with GDM who were 
islet-cell antibody negative31, more than 3 months of lactation was associated with a marked 
reduction in progression to type 2 diabetes (MV-adjusted HR 0.54, 95% CI 0.34–0.85) 
during 19 years of follow-up. In a Canadian study, women with a history of gestational 
diabetes who had breastfed for >10 months had more favorably glucose homeostasis, 
indexed by more favorable fasting insulin concentrations and insulin sensitivity indices32.
Lactation is also associated with differences in hypertension risk. In a Korean cohort study, 
Lee et al found that never-breastfeeding was associated with an increased risk of 
premenopausal hypertension33. Schwarz similarly found that shorter lifetime lactation was 
associated with prevalent hypertension in the Women's Health Initiative24, and Stuebe et al 
found that women who did not breastfeed had a 1.16-fold risk of incident hypertension, 
compared with women who breastfed for at least 12 months per child34. If this association is 
causal, the authors estimated that 12% (95% CI 4.9–19) of incident hypertension could be 
attributed to suboptimal lactation.
Lifetime lactation is also associated with lower risk of metabolic syndrome. Ram et al found 
that each year of lifetime lactation was associated with a 0.88-fold reduction in risk of 
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metabolic syndrome (95% CI 0.77–0.99). Gunderson et al quantified associations with 
metabolic syndrome in the Cardia cohort and found that longer lactation was associated with 
reduced risk. This difference was more pronounced among women with a history of 
gestational diabetes. Among women with GDM who breastfed for a lifetime total of > 9 
months, the odds ratio for metabolic syndrome was 0.14 (95% CI 0.04–0.55) compared with 
having breastfed for 0–1 month lifetime. Among women without a history of GDM, this 
odds ratio was 0.44 (95% CI −.23–0.84). These results suggest that breastfeeding is a 
powerful modifiable risk factor for incident metabolic disease among women with 
pregnancies complicated by GDM.
Maternal lactation history is also associated with differences in incident cardiovascular 
disease. Among parous women in the Nurses' Health Study, lifetime breastfeeding duration 
of >23 months was associated with a 0.77 (95% CI 0.62–0.94) multivariate-adjusted hazard 
ratio of incident myocardial infarction, compared with never having breastfed. This 
association was stronger in the 30 year after a woman's last birth: >23 months of lifetime 
lactation was associated with a 0.66 (95% CI 0.49–.89) multivariate-adjusted hazard ratio, 
compared with never having breastfed. Among parous women in the Women's Health 
Initiative, Schwarz et al found that a lifetime breastfeeding duration of >23 months was 
associated with a multivariate-adjusted OR of 0.86 (95% CI 0.89–0.98) for prevalent 
cardiovascular disease, compared with never having breastfed.
A single randomized controlled trial has evaluated the association between an intervention to 
increase breastfeeding duration and intensity and maternal health35. The PROBIT study was 
a cluster-randomized trial conducted in Repblic of Belarus from 1996 to 1997. The study 
randomized 34 hospitals to implement maternity practices that increase breastfeeding or to 
provide usual care. A total of 17,046 mothers-infant dyads, all of whom initiated 
breastfeeding, were enrolled. The intervention achieved differences in breastfeeding 
duration: At one year, 19.7% of intervention dyads vs 11.4% of control dyads were still 
breastfeeding36. To determine whether the intervention impacted maternal health, mothers 
from the PROBIT underwent evaluation of weight, adiposity and blood pressure at 11.5 
years postpartum. In an intent-to-treat analysis, allocation to the intervention was associated 
with a non-significant reduction in obesity (cluster-adjusted OR 0.90, 95% CI 0.71–1.13), 
body fat ≥40% (cluster-adjusted OR 0.84, 95% CI 0.70,1.01), and hypertension (cluster-
adjusted OR 0.85, 95% CI 0.64, 1.12). The study authors concluded that interventions to 
promote a longer duration of exclusive breastfeeding are unlikely to confer important long-
term benefits for maternal adiposity or blood pressure. However, the lack of important 
differences in the PROBIT sample may reflect the relatively modest impact of the PROBIT 
intervention on long-term breastfeeding, rather than a lack of effect of breastfeeding on 
maternal health. PROBIT women in the control group were more likely to discontinue 
breastfeeding in the first 3 months, compared with women allocated to the intervention (40% 
vs. 27%). Similar proportions of women stopped breastfeeding between 3 and 6 months (37 
vs. 36%), and differences at 6 to 12 months (16 vs. 13%) and 12+ months (20 vs. 11%) were 
small. Applying the covariate-adjusted hazard ratios for incident hypertension from the 
Nurses Health Study34 to the differences breastfeeding rates observed in PROBIT, one 
would predict an odds ratio for hypertension in the intervention vs. control groups of 0.90, 
which is similar to the differences found in the analysis. This exercise suggests that 
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interventions that affect breastfeeding in the first 3 months after birth do not impact long-
term maternal health. To determine a causal association between breastfeeding and maternal 
health, interventions are needed that substantially impact breastfeeding rates from 6 to 12 
months postpartum and beyond.
Potential Mechanisms
Several potential mechanisms may mediate the association between lactation and maternal 
metabolic wellbeing:
1. Lactation may "reset" maternal metabolism after pregnancy
2. Lactation may improve beta cell function
3. Lactation may suppress HPA-axis activity through the action of oxytocin 
and other lactogenic hormones
4. Lactation may be a marker for other maternal health behaviors
5. Underlying metabolic vulnerabilities may adversely affect breastfeeding
The Reset Hypothesis
Lactation imposes a substantial metabolic burden on mothers, and this mobilization of fat 
stores may "reset" maternal metabolism after birth37. From an evolutionary standpoint, 
lactation provides a reliable source of calories in the setting of uncertain resources38. 
Mammals accumulate fat stores during pregnancy in anticipation of mobilizing these stores 
for the infant after birth. If a mother does not lactate, these energy stores are retained, 
potentially increasing metabolic disease risk. Interestingly, maternal energy balance appears 
to be closely tied to the hypothalamic-pituitary ovarian axis: in a longitudinal study of Toba 
women in Argentina, maternal energy balance was correlated with c-peptide levels and 
resumption of menstrual cycles39. Animal studies support a causal association between 
lactation and subsequent adiposity: dams who are separated from their pups after pregnancy 
have great visceral adipose tissue at 1 and 2 months postpartum than dams who lactated40. 
In another animal model of three pregnancies followed by lactation or non-lactation41, non-
lactated dams had substantially higher percent body fat than lactated or non-mated control 
animals (16.7% vs. 10.2% for lactated and 11.0% for controls, p<0.01). These findings 
support the hypothesis that not lactating disrupts normal reproductive physiology, with 
lasting consequences for maternal health.
Beta cell function and lactation
Lactation may also reduce cardiometabolic disease risk through effects on beta-cell function, 
as recently reviewed by Much et al42. During lactation, glucose is diverted into lactocytes to 
support milk synthesis, lowering circulating glucose levels and reducing the need for insulin 
secretion. At the same time, lactating women with recent gestational diabetes had improved 
pancreatic function, compare with women who were formula feeding. McManus et al43 
assessed postpartum metabolic function in 26 Caucasian women (14 lactating, 12 non-
lactating) with gestational diabetes. At three months postpartum, there were no significant 
differences in insulin sensitivity, glucose effectiveness, or visceral fat or subcutaneous fat; 
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however, the lactating group did have a higher disposition index, indicating more efficient 
beta cell function, adjusted for insulin resistance. These differences in insulin secretion may 
reflect the effects of prolactin on beta-cell proliferation. Prolactin down regulates Menin 
during pregnancy in a mouse model of gestational diabetes, leading to beta-cell proliferation 
and improved pancreatic function44. Human studies finding differences in fasting insulin and 
insulin sensitivity after weaning at a function of breastfeeding duration32 suggest that these 
effects may persist, conferring lasting protection from type 2 diabetes among women with 
longer breastfeeding durations.
Stress reactivity
Lactation is associated with differences in maternal stress reactivity. Altemus45 compared 
responses to an exercise treadmill test among lactating and non-lactating mothers and found 
lower ACTH and cortisol levels in the lactating group. Some of this buffering of the stress 
response appears to be dependent on time since the mother last fed: Heinrichs46 tested 
ACTH and cortisol responses to a social stressor among 43 lactating women; half were 
asked to breastfeed before their appointment, and half breastfed immediately before the 
stressor. Women who breastfed 30 minutes before the stressor had similar levels of ACTH, 
but reduced levels of salivary cortisol, compared with women who breastfed 100 minutes 
before the stressor. The buffering affect may also vary between primiparous and multiparous 
women: Tu47 found similar cortisol responses to a stressor among breastfeeding and 
formula-feeding primiparous women, but among multiparous women, the cortisol response 
was reduced in breastfeeding compared with formula-feeding women. Other studies have 
found that women who are lactating display greater aggression when confronted, yet 
experience less physical stress, evidenced by lower systolic and diastolic blood pressure 
during a confrontation48.
The hormone oxytocin is thought to modulate HPA axis activity, and prolonged potentiation 
of oxytocin pathways in lactation may affect vascular function as well. Among postpartum 
women, higher oxytocin is associated with decreased sympathetic reactivity to stress49. 
Animal studies have found that oxytocin blunts both cardiovascular and neuroendocrine 
responses to stress and reduces anxiety-like behavior, whereas oxytocin antagonists increase 
cardiovascular response to stressors17. There is tentative evidence that longer lactation is 
associated with long-term changes in maternal HPA axis activity: longer lifetime 
breastfeeding history was associated with higher morning cortisol levels among 
postmenopausal women50.
Lactation as a marker for other health behaviors
In the US, mothers who breastfeed differ from mothers who formula feed: they are older, 
wealthier, better educated, less likely to smoke, and more likely to engage in other beneficial 
health behaviors51–53. To the extent that these health behaviors are associated with long-term 
maternal cardiometabolic health, these health behaviors, rather than breastfeeding itself, may 
underlie epidemiologic associations between breastfeeding and long-term maternal health. 
Importantly, epidemiologic studies have adjusted for multiple health behaviors, including 
current diet, physical activity, and tobacco use, reducing the influence of these confounders. 
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Nevertheless, unmeasured or residual confounding may explain some of the association 
between lactation and maternal health.
Differences in outcomes may also reflect the constraints that can prevent women from 
initiating and sustaining breastfeeding. Women employed in part-time or hourly wage jobs 
are less likely to have access to paid maternity leave, and early return to work is associated 
with shorter breastfeeding duration54. Moreover, disparities in health care systems may 
affect breastfeeding rates. For example, a recent analysis found that neighborhood racial 
composition was associated with provision of evidence-based maternity practices that 
support successful breastfeeding. Compared with hospitals in neighborhoods with ≤12.2% 
black residents, hospitals in neighborhoods with >12.2% black residents were less likely to 
meet 5 of the 10 indicators for recommended maternity care practices55. Successful, long-
term breastfeeding may be therefore be a marker for access to high-quality health care, 
rather than a mechanism to reduce risk. However, if the capacity to breastfeed, rather than 
breastfeeding itself, improves long-term health outcomes for mothers, we must take steps to 
ensure that all women have the capacity to achieve their infant feeding goals.
Underlying metabolic health and breastfeeding outcomes
It is also plausible that underlying metabolic vulnerabilities affect a woman's ability to 
initiate and sustain breastfeeding. In animal studies, excess adiposity is associated with poor 
milk production and failed lactogenesis56, and among women, higher maternal body mass 
index is associated with lower initiation and reduced duration of lactation. Baker et al 
measured duration of lactation among women in Denmark as a function of pregravid BMI 
and found lower durations of both exclusive and any breastfeeding among overweight and 
obese women, compared with women with a normal pregravid BMI57. These findings are 
consistent with other studies of populations in the US58,59 and Australia60,61, as well as two 
recent meta-analyses62,63. While psychosocial factors appear to explain the association with 
total breastfeeding duration64 in a US study, these factors did not explain the association 
between maternal BMI and exclusive breastfeeding, lending support to the hypothesis that 
greater adiposity impacts a woman's ability to meet 100% of her infant's feeding needs. 
Authors have similarly found that women with pre-gestational diabetes are less likely to 
intend to breastfeed than women without diabetes, and women with either gestational or pre-
gestational diabetes are less likely to breastfeed in the hospital or to be breastfeeding at 
hospital discharge65. Both GDM and pre-gestational diabetes were also associated with 
reduced breastfeeding duration in the PRAMS population66.
Several mechanisms may underlie these associations. In a small study, Rasmussen et al 
found differences between prolactin levels in normal weight vs. overweight women at 
baseline and 30 minutes after feeding67. Other evidence suggests that both obesity and 
insulin resistance may play a role in lactogenesis II. Nommsen-Rivers et al found that high 
BMI was associated with markedly higher rates of delayed onset of lactogenesis68: 53.8% of 
obese women experienced onset of lactogenesis more than 72 hours postpartum, compared 
with 44.8% of overweight women and 31.4% of normal weight women. In a subsequent 
study, Nommsen-Rivers further found that maternal metabolic health during pregnancy, 
indexed by insulin-to-glucose ratio after a 50g glucose load, was correlated with earlier 
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onset of lactogenesis69. Matias et al similarly found a relationship between metabolic health 
during pregnancy and early breastfeeding outcomes. In the SWIFT cohort of women with 
gestational diabetes, both prepregnancy obesity and insulin treatment during pregnancy were 
associated with delayed onset of lactogenesis70. These observational findings correlated with 
recent translational work linking early milk supply problems and insulin resistance: Lemay 
et al found that supply issues were associated with increased expression of protein tyrosine 
phosphatase, receptor type, F (PTPRF), a protein that interferes with insulin signaling2. 
These data suggest that underlying insulin resistance may interfere with lactation 
physiology, supporting the hypothesis that successful breastfeeding may be a marker for 
metabolic well-being.
Clinical implications
In population studies, never or curtailed breastfeeding is associated with adverse 
cardiometabolic outcomes. While some of these associations may be explained by 
confounding behaviors and underlying maternal metabolic disease risk, the existing evidence 
suggests that enabling women to initiate and sustain breastfeeding can improve long-term 
health maternal health. Therefore, women's health providers should optimize each a 
woman's ability to breastfeed her infant71,72. Providers should ensure that the outpatient 
office is conducive to breastfeeding, beginning with provisions for lactating office 
employees to express milk during the workday. Formula marketing materials should not be 
present in the health care settings73. Breastfeeding should be welcome in waiting areas, and 
ideally, nursing mothers should be offered the option of a private area to feed if they would 
feel more comfortable there. Providers and staff should understand the nuances of 
medication safety in lactation and be a resource for evidence-based advice. Breastfeeding 
should be discussed in prenatal care and anticipatory guidance provided. Maternity providers 
should work with hospitals to implement the Ten Steps to Baby Friendly Maternity Care in 
order to increase each woman's likelihood of achieving her own breastfeeding goals74.
In the early postpartum period, maternal obesity and insulin resistance impact the 
management of the breastfed neonate. Infants that are large for gestational age or whose 
mothers have diabetes are at risk of complications such as hypoglycemia and neonatal 
jaundice, and monitoring and management protocols should be designed to optimize 
establishment of breastfeeding. For example, early, prolonged skin-to-skin care after birth 
increases infant glucose levels: in a Cochrane meta-analysis, continuous skin-to-skin care 
increased neonatal glucose levels at 60–75 minutes after birth by 10.56 mg/dL75. Such skin-
to-skin care can be provided during cesarean births, and is associated with reduced formula 
supplementation during the maternity stay76. For infants requiring monitoring for 
hypoglycemia, ongoing skin-to-skin care and feeding of hand-expressed colostrum or donor 
human milk can obviate the need to supplement with formula. Similarly, for infants with 
jaundice, family-centered care plans such as bilirubin blankets can facilitate breastfeeding 
during treatment77. Such provisions are outlined in the Academy of Breastfeeding Medicine 
protocols for hypoglycemia78 and jaundice79. Following hospital discharge, the maternity 
provider should be a resource for breastfeeding families, working closely with the infant's 
provider and with lactation consultants to address any breastfeeding challenges.
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Several studies have tested interventions to improve breastfeeding outcomes among 
overweight or obese women, with mixed results. Rasmussen et al tested phone support and 
early initiation of pumping among 74 women in New York State and found that neither 
intervention improved breastfeeding outcomes80. Chapman et al tested a peer counselor 
intervention tailored to the perceived needs of overweight and obese women among 206 
women in Connecticut and found higher rates of any and >50% breastfeeding at 2 weeks 
postpartum, but no other differences in breastfeeding rates81. Carlsen et al tested an IBCLC 
phone support intervention among 226 obese women in Denmark and increased both any 
and exclusive breastfeeding duration82. Carlsen's findings suggest that targeted support may 
improve outcomes among women at metabolic risk, but it remains to be determined what 
strategy may be most effective within the United States.
Conclusion
Among parous women, longer lactation is associated with lower risks of diabetes, 
hypertension, metabolic syndrome, and myocardial infarction. Several mechanisms may 
mediate these associations; underlying differences in health behavior and health status 
between women who decide to breastfed and women who decide not to breastfeed likely 
play a role. However, evidence suggests that enabling a woman to initiate and sustain 
breastfeeding has the potential to reduce her lifetime risk of cardiometabolic disease. 
Women's health providers should therefore make every effort to share this evidence with 
women to inform their feeding decision, and to provide evidence-based care that optimizes 
each woman's likelihood of achieving her breastfeeding goals.
Acknowledgments
This manuscript was supported in part by R01HL109216-01A1, Lactation Effects on Postnatal Endothelial 
Function and Vascular Inflammation. The content is solely the responsibility of the author and does not necessarily 
represent the official views of the National Institutes of Health.
References
1. Pang WW, Hartmann PE. Initiation of human lactation: secretory differentiation and secretory 
activation. J Mammary Gland Biol Neoplasia. 2007 Dec; 12(4):211–221. [PubMed: 18027076] 
2. Lemay DG, Ballard OA, Hughes MA, Morrow AL, Horseman ND, Nommsen-Rivers LA. RNA 
sequencing of the human milk fat layer transcriptome reveals distinct gene expression profiles at 
three stages of lactation. PLoS ONE. 2013; 8(7):e67531. [PubMed: 23861770] 
3. Butte NF, Wong WW, Hopkinson JM. Energy Requirements of Lactating Women Derived from 
Doubly Labeled Water and Milk Energy Output. J. Nutr. 2001 Jan 1; 131(1):53–58. 2001. [PubMed: 
11208938] 
4. Lovelady CA, Garner KE, Moreno KL, Williams JP. The Effect of Weight Loss in Overweight, 
Lactating Women on the Growth of Their Infants. The New England journal of medicine. 2000 Feb 
17; 342(7):449–453. 2000. [PubMed: 10675424] 
5. Dewey KG, Heinig MJ, Nommsen LA. Maternal weight-loss patterns during prolonged lactation. 
The American journal of clinical nutrition. 1993; 58(2):162–166. [PubMed: 8338042] 
6. Baker JL, Gamborg M, Heitmann BL, Lissner L, Sorensen TI, Rasmussen KM. Breastfeeding 
reduces postpartum weight retention. The American journal of clinical nutrition. 2008 Dec; 88(6):
1543–1551. [PubMed: 19064514] 
Stuebe Page 10













7. Ohlin A, Rossner S. Factors related to body weight changes during and after pregnancy: the 
Stockholm Pregnancy and Weight Development Study. Obesity Res. 1996 May 1; 4(3):271–276. 
1996. 
8. Dewey KG, Cohen RJ, Brown KH, Rivera LL. Effects of Exclusive Breastfeeding for Four versus 
Six Months on Maternal Nutritional Status and Infant Motor Development: Results of Two 
Randomized Trials in Honduras. J Nutr. 2001 Feb 1; 131(2):262–267. 2001. [PubMed: 11160544] 
9. Kjos SL, Henry O, Lee RM, Buchanan TA, Mishell DR Jr. The effect of lactation on glucose and 
lipid metabolism in women with recent gestational diabetes. Obstetrics and gynecology. 1993; 
82(3):451–455. [PubMed: 8355952] 
10. O'Reilly MW, Avalos G, Dennedy MC, O'Sullivan EP, Dunne F. Atlantic DIP: high prevalence of 
abnormal glucose tolerance post partum is reduced by breast-feeding in women with prior 
gestational diabetes mellitus. Eur J Endocrinol. 2011 Dec; 165(6):953–959. [PubMed: 21937504] 
11. Gunderson EP, Crites Y, Chiang V, et al. Influence of breastfeeding during the postpartum oral 
glucose tolerance test on plasma glucose and insulin. Obstetrics and gynecology. 2012 Jul; 120(1):
136–143. [PubMed: 22914402] 
12. Darmady JM, Postle AD. Lipid metabolism in pregnancy. BJOG. 1982; 89(3):211–215.
13. Knopp RH, Walden CE, Wahl PW, et al. Effect of postpartum lactation on lipoprotein lipids and 
apoproteins. J Clin Endocrinol Metab. 1985; 60(3):542–547. [PubMed: 3972965] 
14. Erkkola R, Viikari J, Irjala K, Solakivi-Jaakkola T. One-year follow-up of lipoprotein metabolism 
after pregnancy. Biol Res Pregnancy Perinatol. 1986; 7(2):47–51. [PubMed: 3730470] 
15. Kallio MJ, Siimes MA, Perheentupa J, Salmenpera L, Miettinen TA. Serum cholesterol and 
lipoprotein concentrations in mothers during and after prolonged exclusive lactation. Metabolism: 
Clinical & Experimental. 1992; 41(12):1327–1330. [PubMed: 1461138] 
16. Gunderson EP, Kim C, Quesenberry CP Jr, et al. Lactation intensity and fasting plasma lipids, 
lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with 
recent gestational diabetes mellitus: the SWIFT cohort. Metabolism: Clinical & Experimental. 
2014 Jul; 63(7):941–950. [PubMed: 24931281] 
17. Japundzic-Zigon N. Vasopressin and oxytocin in control of the cardiovascular system. Current 
neuropharmacology. 2013 Mar; 11(2):218–230. [PubMed: 23997756] 
18. Petersson M, Alster P, Lundeberg T, Uvnas-Moberg K. Oxytocin causes a long-term decrease of 
blood pressure in female and male rats. Physiology & behavior. 1996; 60(5):1311–1315. [PubMed: 
8916187] 
19. Petersson M, Lundeberg T, Uvnas-Moberg K. Short-term increase and long-term decrease of blood 
pressure in response to oxytocin-potentiating effect of female steroid hormones. Journal of 
Cardiovascular Pharmacology. 1999; 33(1):102–108. [PubMed: 9890403] 
20. Mezzacappa ES, Kelsey RM, Katkin ES. Breast feeding, bottle feeding, and maternal autonomic 
responses to stress. Journal of Psychosomatic Research. 2005; 58(4):351–365. [PubMed: 
15992571] 
21. Rooney B, Schauberger C. Excess pregnancy weight gain and long-term obesity: one decade later. 
Obstetrics and gynecology. 2002 Aug; 100(2):245–252. [PubMed: 12151145] 
22. Bobrow KL, Quigley MA, Green J, Reeves GK, Beral V, Million Women Study C. Persistent 
effects of women's parity and breastfeeding patterns on their body mass index: results from the 
Million Women Study. Int J Obes (Lond). 2013 May; 37(5):712–717. [PubMed: 22777544] 
23. Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB. Duration of lactation and 
incidence of Type 2 Diabetes. JAMA. 2005 Nov 23; 294(20):2601–2610. 2005. [PubMed: 
16304074] 
24. Schwarz EB, Ray RM, Stuebe AM, et al. Duration of lactation and risk factors for maternal 
cardiovascular disease. Obstetrics and gynecology. 2009 May; 113(5):974–982. [PubMed: 
19384111] 
25. Schwarz EB, Brown JS, Creasman JM, et al. Lactation and maternal risk of type 2 diabetes: a 
population-based study. Am J Med. 2010 Sep; 123(9):863, e861–e866. [PubMed: 20800156] 
26. Villegas R, Gao YT, Yang G, et al. Duration of breast-feeding and the incidence of type 2 diabetes 
mellitus in the Shanghai Women's Health Study. Diabetologia. 2008 Feb; 51(2):258–266. 
[PubMed: 18040660] 
Stuebe Page 11













27. Liu B, Jorm L, Banks E. Parity, breastfeeding, and the subsequent risk of maternal type 2 diabetes. 
Diabetes Care. 2010 Jun; 33(6):1239–1241. [PubMed: 20332359] 
28. Natland ST, Nilsen TI, Midthjell K, Andersen LF, Forsmo S. Lactation and cardiovascular risk 
factors in mothers in a population-based study: the HUNT-study. International breastfeeding 
journal. 2012; 7(1):8. [PubMed: 22713515] 
29. Jager S, Jacobs S, Kroger J, et al. Breast-feeding and maternal risk of type 2 diabetes: a prospective 
study and meta-analysis. Diabetologia. 2014 Jul; 57(7):1355–1365. [PubMed: 24789344] 
30. Aune D, Norat T, Romundstad P, Vatten LJ. Breastfeeding and the maternal risk of type 2 diabetes: 
a systematic review and dose-response meta-analysis of cohort studies. Nutr Metab Cardiovasc 
Dis. 2014 Feb; 24(2):107–115. [PubMed: 24439841] 
31. Ziegler AG, Wallner M, Kaiser I, et al. Long-term protective effect of lactation on the development 
of type 2 diabetes in women with recent gestational diabetes mellitus. Diabetes. 2012 Dec; 61(12):
3167–3171. [PubMed: 23069624] 
32. Chouinard-Castonguay S, Weisnagel SJ, Tchernof A, Robitaille J. Relationship between lactation 
duration and insulin and glucose response among women with prior gestational diabetes. Eur J 
Endocrinol. 2013 Apr; 168(4):515–523. [PubMed: 23302255] 
33. Lee SY, Kim MT, Jee SH, Yang HP. Does long-term lactation protect premenopausal women 
against hypertension risk? A Korean women's cohort study. Prev Med. 2005; 41(2):433–438. 
[PubMed: 15917038] 
34. Stuebe AM, Schwarz EB, Grewen K, et al. Duration of lactation and incidence of maternal 
hypertension: a longitudinal cohort study. Am J Epidemiol. 2011 Nov 15; 174(10):1147–1158. 
[PubMed: 21997568] 
35. Oken E, Patel R, Guthrie LB, et al. Effects of an intervention to promote breastfeeding on maternal 
adiposity and blood pressure at 11.5 y postpartum: results from the Promotion of Breastfeeding 
Intervention Trial, a cluster-randomized controlled trial. The American journal of clinical nutrition. 
2013 Oct; 98(4):1048–1056. [PubMed: 23945719] 
36. Kramer MS, Chalmers B, Hodnett ED, et al. Promotion of Breastfeeding Intervention Trial 
(PROBIT): A Randomized Trial in the Republic of Belarus. JAMA. 2001 Jan 24; 285(4):413–420. 
2001. [PubMed: 11242425] 
37. Stuebe AM, Rich-Edwards JW. The reset hypothesis: lactation and maternal metabolism. Am J 
Perinatol. 2009 Jan; 26(1):81–88. [PubMed: 19031350] 
38. Dall SR, Boyd IL. Evolution of mammals: lactation helps mothers to cope with unreliable food 
supplies. Proc Biol Sci. 2004 Oct 7; 271(1552):2049–2057. [PubMed: 15451695] 
39. Valeggia C, Ellison PT. Interactions between metabolic and reproductive functions in the 
resumption of postpartum fecundity. Am J Hum Biol. 2009 Jul-Aug;21(4):559–566. [PubMed: 
19298003] 
40. Poole AT, Vincent KL, Olson GL, et al. Effect of lactation on maternal postpartum cardiac function 
and adiposity: a murine model. American journal of obstetrics and gynecology. 2014 Jun 3.
41. Zhong S, Almario R, Dubrinsky M, et al. Repeated pregnancy without lactation: effects on 
maternal glycemic control, pregnancy outcome, carcass composition, and fat distribution in rats. 
Metabolism: Clinical & Experimental. 1990 Nov; 39(11):1127–1132. [PubMed: 2233272] 
42. Much D, Beyerlein A, Rossbauer M, Hummel S, Ziegler AG. Beneficial effects of breastfeeding in 
women with gestational diabetes mellitus. Molecular metabolism. 2014 Jun; 3(3):284–292. 
[PubMed: 24749058] 
43. McManus RM, Cunningham I, Watson A, Harker L, Finegood DT. Beta-cell function and visceral 
fat in lactating women with a history of gestational diabetes. Metabolism: Clinical & 
Experimental. 2001; 50(6):715–719. [PubMed: 11398150] 
44. Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic beta-cells in pregnant 
mice and promotes gestational diabetes mellitus. Science. 2007 Nov 2; 318(5851):806–809. 
[PubMed: 17975067] 
45. Altemus M, Redwine LS, Leong Y-M, Frye CA, Porges SW, Carter CS. Responses to Laboratory 
Psychosocial Stress in Postpartum Women. Psychosom Med. 2001 Sep 1; 63(5):814–821. 2001. 
[PubMed: 11573030] 
Stuebe Page 12













46. Heinrichs M, Meinlschmidt G, Neumann I, et al. Effects of Suckling on Hypothalamic-Pituitary-
Adrenal Axis Responses to Psychosocial Stress in Postpartum Lactating Women. J Clin 
Endocrinol Metab. 2001 Oct 1; 86(10):4798–4804. 2001. [PubMed: 11600543] 
47. Tu MT, Lupien SJ, Walker CD. Multiparity reveals the blunting effect of breastfeeding on 
physiological reactivity to psychological stress. J Neuroendocrinol. 2006 Jul; 18(7):494–503. 
[PubMed: 16774498] 
48. Hahn-Holbrook J, Holt-Lunstad J, Holbrook C, Coyne SM, Lawson ET. Maternal Defense: Breast 
Feeding Increases Aggression by Reducing Stress. Psychological Science. 2011 Oct 1; 22(10):
1288–1295. 2011. [PubMed: 21873570] 
49. Grewen KM, Light KC. Plasma oxytocin is related to lower cardiovascular and sympathetic 
reactivity to stress. Biol Psychol. 2011 Jul; 87(3):340–349. [PubMed: 21540072] 
50. Lankarani-Fard A, Kritz-Silverstein D, Barrett-Connor E, Goodman-Gruen D. Cumulative duration 
of breast-feeding influences cortisol levels in postmenopausal women. Journal of Womens Health 
& Gender-Based Medicine. 2001 Sep; 10(7):681–687.
51. Beck LF, Morrow B, Lipscomb LE, et al. Prevalence of selected maternal behaviors and 
experiences, Pregnancy Risk Assessment Monitoring System (PRAMS), 1999. MMWR Surveill 
Summ. 2002; 51(2):1–27. [PubMed: 12004983] 
52. Pesa JA, Shelton MM. Health-enhancing behaviors correlated with breastfeeding among a national 
sample of mothers. Public health nursing (Boston, Mass. 1999; 16(2):120–124.
53. Jones JR, Kogan MD, Singh GK, Dee DL, Grummer-Strawn LM. Factors Associated With 
Exclusive Breastfeeding in the United States. Pediatrics. 2011; 128(6):1117–1125. [PubMed: 
22123898] 
54. Sparks PJ. Racial/ethnic differences in breastfeeding duration among WIC-eligible families. 
Womens Health Issues. 2011 Sep-Oct;21(5):374–382. [PubMed: 21565528] 
55. Lind JN, Perrine CG, Li R, Scanlon KS, Grummer-Strawn LM. Racial disparities in access to 
maternity care practices that support breastfeeding - United States, 2011. Mmwr. 2014 Aug 22; 
63(33):725–728. [PubMed: 25144543] 
56. Rasmussen KM, Hilson JA, Kjolhede CL. Obesity may impair lactogenesis II. Journal of Nutrition. 
2001; 131(11):3009S–3011S. [PubMed: 11694637] 
57. Baker JL, Michaelsen KF, Sorensen TI, Rasmussen KM. High prepregnant body mass index is 
associated with early termination of full and any breastfeeding in Danish women. The American 
journal of clinical nutrition. 2007 Aug; 86(2):404–411. [PubMed: 17684212] 
58. Hilson JA, Rasmussen KM, Kjolhede CL. Maternal obesity and breast-feeding success in a rural 
population of white women. The American journal of clinical nutrition. 1997 Dec; 66(6):1371–
1378. [PubMed: 9394689] 
59. Hilson JA, Rasmussen KM, Kjolhede CL. High prepregnant body mass index is associated with 
poor lactation outcomes among white, rural women independent of psychosocial and demographic 
correlates. J Hum Lact. 2004 Feb; 20(1):18–29. [PubMed: 14974697] 
60. Oddy W, Li J, Landsborough L, Kendall G, Henderson S, Downie J. The association of maternal 
overweight and obesity with breastfeeding duration. J Pediatr. 2006 Aug 1; 149(2):185–191. 2006. 
[PubMed: 16887431] 
61. Donath SM, Amir LH. Does maternal obesity adversely affect breastfeeding initiation and 
duration? Breastfeed Rev. 2000; 8(3):29–33. [PubMed: 11210280] 
62. Amir L, Donath S. A systematic review of maternal obesity and breastfeeding intention, initiation 
and duration. BMC Pregnancy and Childbirth. 2007; 7(1):9. [PubMed: 17608952] 
63. Wojcicki JM. Maternal prepregnancy body mass index and initiation and duration of breastfeeding: 
a review of the literature. J Womens Health (Larchmt). 2011 Mar; 20(3):341–347. [PubMed: 
21434834] 
64. Hauff LE, Leonard SA, Rasmussen KM. Associations of maternal obesity and psychosocial factors 
with breastfeeding intention, initiation, and duration. The American journal of clinical nutrition. 
2014 Mar; 99(3):524–534. [PubMed: 24401717] 
65. Finkelstein SA, Keely E, Feig DS, Tu X, Yasseen AS 3rd, Walker M. Breastfeeding in women with 
diabetes: lower rates despite greater rewards. A population-based study. Diabet Med. 2013 May 
22.
Stuebe Page 13













66. Oza-Frank R, Chertok I, Bartley A. Differences in breast-feeding initiation and continuation by 
maternal diabetes status. Public Health Nutr. 2015 Mar; 18(4):727–735. [PubMed: 24809929] 
67. Rasmussen KM, Kjolhede CL. Prepregnant overweight and obesity diminish the prolactin response 
to suckling in the first week postpartum. Pediatrics. 2004 May; 113(5):e465–e471. [PubMed: 
15121990] 
68. Nommsen-Rivers LA, Chantry CJ, Peerson JM, Cohen RJ, Dewey KG. Delayed onset of 
lactogenesis among first-time mothers is related to maternal obesity and factors associated with 
ineffective breastfeeding. The American journal of clinical nutrition. 2010 Sep; 92(3):574–584. 
[PubMed: 20573792] 
69. Nommsen-Rivers LA, Dolan LM, Huang B. Timing of stage II lactogenesis is predicted by 
antenatal metabolic health in a cohort of primiparas. Breastfeeding medicine : the official journal 
of the Academy of Breastfeeding Medicine. 2012 Feb; 7(1):43–49. [PubMed: 21524193] 
70. Matias SL, Dewey KG, Quesenberry CP Jr, Gunderson EP. Maternal prepregnancy obesity and 
insulin treatment during pregnancy are independently associated with delayed lactogenesis in 
women with recent gestational diabetes mellitus. The American journal of clinical nutrition. 2014 
Jan; 99(1):115–121. [PubMed: 24196401] 
71. Stuebe AM. Enabling Women to Achieve Their Breastfeeding Goals. Obstetrics and gynecology. 
2014 Feb 4.
72. Clinical Protocol Number #19: Breastfeeding Promotion in the Prenatal Setting. Breastfeeding 
Medicine. 2009; 4(1):43–45. [2009/03/01] [PubMed: 19301463] 
73. Howard CR, Howard FM, Lawrence RA, Andresen E, DeBlieck E, Weitzman M. Office Prenatal 
Formula Advertising and Its Effect on Breast-Feeding Patterns. Obstetrics and gynecology. 2000 
Feb 1; 95(2):296–303. 2000. [PubMed: 10674597] 
74. DiGirolamo AM, Grummer-Strawn LM, Fein SB. Effect of Maternity-Care Practices on 
Breastfeeding. Pediatrics. 2008 Oct 1; 122(Supplement_2):S43–S49. 2008. [PubMed: 18829830] 
75. Moore ER, Anderson GC, Bergman N, Dowswell T. Early skin-to-skin contact for mothers and 
their healthy newborn infants. The Cochrane database of systematic reviews. 2012; 5:CD003519. 
[PubMed: 22592691] 
76. Hung KJ, Berg O. Early skin-to-skin after cesarean to improve breastfeeding. MCN. The American 
journal of maternal child nursing. 2011 Sep-Oct;36(5):318–324. quiz 325–316. [PubMed: 
21743355] 
77. Szucs KA, Rosenman MB. Family-centered, evidence-based phototherapy delivery. Pediatrics. 
2013 Jun; 131(6):e1982–e1985. [PubMed: 23669526] 
78. Wight N, Marinelli KA. ABM Clinical Protocol #1: Guidelines for Blood Glucose Monitoring and 
Treatment of Hypoglycemia in Term and Late-Preterm Neonates, Revised 2014. Breastfeeding 
Medicine. 2014; 9(4):173–179. [2014/05/01] [PubMed: 24823918] 
79. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 
Equal to or Greater Than 35 Weeks' Gestation. Breastfeeding Medicine. 2010; 5(2):87–93. 
[2010/04/01] [PubMed: 20387269] 
80. Rasmussen KM, Dieterich CM, Zelek ST, Altabet JD, Kjolhede CL. Interventions to increase the 
duration of breastfeeding in obese mothers: the Bassett Improving Breastfeeding Study. Breastfeed 
Med. 2011 Apr; 6(2):69–75. [PubMed: 20958105] 
81. Chapman DJ, Morel K, Bermudez-Millan A, Young S, Damio G, Perez-Escamilla R. Breastfeeding 
education and support trial for overweight and obese women: a randomized trial. Pediatrics. 2013 
Jan; 131(1):e162–e170. [PubMed: 23209111] 
82. Carlsen EM, Kyhnaeb A, Renault KM, Cortes D, Michaelsen KF, Pryds O. Telephone-based 
support prolongs breastfeeding duration in obese women: a randomized trial. The American 
journal of clinical nutrition. 2013 Nov; 98(5):1226–1232. [PubMed: 24004897] 
Stuebe Page 14
Clin Obstet Gynecol. Author manuscript; available in PMC 2016 December 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
